IMUX
Immunic, Inc. : H.c. Wainwright Initiates Coverage With Buy Rating
时间：2024-11-25 19:02:31 市场： 美股 综合
Immunic Announces Publication of Data From Phase 1/1B Clinical Trial of Imu-856 in the Peer Reviewed Journal, the Lancet Gastroenterology & Hepatology
时间：2024-11-13 19:30:07 市场： 综合 美股
Immunic Shares up 11.3% After Co Reports Interim Late-Stage Data for Multiple Sclerosis Drug
时间：2024-10-22 21:31:36 市场： 综合
Immunic: Idmc Recommended Continuing Trial Without Changes, Including No Need for Potential Upsizing
时间：2024-10-22 18:30:27 市场： 美股 综合
Immunic Announces Positive Outcome of Interim Analysis of Phase 3 Ensure Program of Vidofludimus Calcium in Relapsing Multiple Sclerosis
时间：2024-10-22 18:30:27 市场： 美股 综合